The aging population of the Western world will lead to an increase in cardiac pathologies. Valvular disorders include a spectrum of progressive diseases that confers mechanical and functional impairment, including issues with the cardiac conduction system. Pacemakers are a therapeutic standard to reinstate the synchrony of cardiac contraction. Permanent pacemakers are often required for severe, chronic presentations and have been effective in nullifying symptoms and improving cardiac function. Yet, these devices impart new risks and complications that require additional interventions. However, recent advancements in leadless pacemakers and cardiac resynchronization therapy provide a novel approach to applying pacemaker technology and have been shown to reduce associated risks and improve patient outcomes.